© 2025 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
Spencer, Assistant Editor of CURE®, has been with MJH Life Sciences since 2024. A graduate of Rowan University with a bachelor's degree in health communication, Spencer manages CURE's Facebook, Instagram and YouTube. He also enjoys spending time with family and friends, hiking, playing guitar and rock climbing.
Sarcoma is a rare cancer of connective tissues that requires specialized diagnosis and care tailored to tumor type, stage, and patient needs.
Sarcoma is a rare and complex type of cancer that forms in connective tissues, which include bones, muscles, fat, tendons, blood vessels and nerves. Unlike most cancers that begin in organs such as the lungs or breast, sarcomas start in the body’s structural tissues. Because they can develop almost anywhere, diagnosis and treatment often require a specialized, multidisciplinary team.
There are two broad categories of sarcoma: soft tissue sarcoma and bone sarcoma.
Soft tissue sarcoma can occur in nearly any part of the body, most commonly in the arms, legs, chest or abdomen. There are more than 50 subtypes, including:
Bone sarcoma begins in the bone itself. The two most recognized subtypes are:
Staging describes how advanced the sarcoma is and helps guide treatment planning. It takes into account the tumor’s size, grade and whether it has spread.
Because sarcoma is uncommon, accurate staging often requires evaluation by a sarcoma specialist who can interpret imaging and biopsy results.
Genetic changes play a key role in many sarcomas. Some are caused by specific chromosomal translocations, where pieces of DNA swap places and form new fusion genes that drive tumor growth. Others are linked to inherited genetic syndromes, such as:
However, most sarcomas occur sporadically, without a clear inherited component. Genetic testing may help determine treatment options and identify whether family members could be at risk.
Because sarcoma can appear in many locations and mimic benign growths, diagnosis can be challenging.
The diagnostic process usually begins with imaging studies:
A biopsy—the removal of a small tissue sample — is essential for confirming the diagnosis. The sample is reviewed by a pathologist experienced in sarcoma, who determines the subtype and grade. The tumor’s grade reflects how abnormal the cells look and how quickly they are likely to grow and spread.
Patients should ask whether their biopsy and imaging will be reviewed by a sarcoma specialist or at a comprehensive cancer center with expertise in these rare cancers.
Treatment depends on the sarcoma’s type, location, grade, and stage, as well as the patient’s overall health and goals of care. Many patients benefit from a team approach that includes oncologists, surgeons, radiation oncologists and rehabilitation specialists.
Surgery remains the mainstay of treatment for localized sarcoma. The goal is to remove the entire tumor with clear margins, meaning no cancer cells are left behind.
For bone or limb sarcomas, surgeons often perform limb-sparing procedures to avoid amputation whenever possible. In some cases, reconstructive surgery or bone grafts may be needed to restore function.
Radiation therapy may be used before surgery to shrink the tumor and make it easier to remove, or after surgery to destroy remaining cancer cells. Radiation can also relieve pain or control symptoms when sarcoma cannot be fully removed.
Newer radiation techniques, such as intensity-modulated radiation therapy (IMRT) or proton therapy, allow for more precise targeting while minimizing damage to nearby healthy tissue.
Chemotherapy uses drugs that travel through the bloodstream to destroy cancer cells. It may be used before surgery to shrink tumors, after surgery to reduce recurrence risk or for metastatic disease.
Certain subtypes, such as Ewing sarcoma or osteosarcoma, are more sensitive to chemotherapy. Common drugs include doxorubicin, ifosfamide and dacarbazine. Oncologists tailor regimens to each patient’s diagnosis and tolerance.
Some sarcomas respond to targeted therapies, which block specific genetic changes that drive cancer growth. For example, gastrointestinal stromal tumors (GISTs) often respond to targeted therapy that inhibits the KIT or PDGFRA proteins.
Immunotherapy, which activates the body’s immune system to attack cancer cells, has shown promise for certain sarcoma types and is an active area of research. Clinical trials may offer access to newer options not yet available through standard treatment.
Treatment for sarcoma can cause side effects such as fatigue, nausea, pain and changes in mobility. Physical therapy, pain management and nutritional support can improve recovery and quality of life.
Patients should work closely with their care team to report symptoms early. Managing side effects proactively can prevent complications and support long-term well-being.
A sarcoma diagnosis can be emotionally taxing for patients and loved ones. Support from mental health professionals, patient navigators or cancer support groups can help manage anxiety and uncertainty throughout treatment.
After treatment, survivorship care focuses on monitoring for recurrence, managing long-term side effects and promoting healthy living. Follow-up care usually includes regular physical exams and imaging, especially during the first few years when recurrence risk is highest.
Patients are encouraged to discuss fertility, employment, exercise and nutrition with their oncologist or survivorship team.
Sarcoma can return at the original site or spread to distant organs, most often the lungs. The likelihood of recurrence depends on tumor grade, size and surgical margins.
If sarcoma returns, additional surgery, radiation or systemic therapy may be recommended. Ongoing surveillance and prompt reporting of new symptoms — such as persistent cough, pain or swelling — can allow for earlier detection and intervention.
Editor’s Note: This guide is designed to be a starting point. Your personal experience will be unique. By using this information as a foundation for your discussions, you can partner with your oncologist to make the best decisions for your health.
For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Related Content: